Results 1 to 10 of about 136,322 (339)

Characterization of anti-canine CD20 antibody 4E1-7-B_f and comparison with commercially available anti-human CD20 antibodies. [PDF]

open access: yesPLoS ONE
This study characterizes the previously reported anti-canine CD20 antibody 4E1-7-B_f and compares this with commercially available anti-human CD20 antibodies, rituximab and an obinutuzumab biosimilar.
Takuya Mizuno   +3 more
doaj   +2 more sources

CD20 and CD19 targeted vectors induce minimal activation of resting B lymphocytes [PDF]

open access: yes, 2013
B lymphocytes are an important cell population of the immune system. However, until recently it was not possible to transduce resting B lymphocytes with retro- or lentiviral vectors, making them unsusceptible for genetic manipulations by these vectors ...
A Pezzutto   +51 more
core   +17 more sources

CD4 and CD20 as important immune markers in patients with pulmonary tuberculosis [PDF]

open access: yesE3S Web of Conferences, 2023
Tuberculosis (TB) is a serious lung infection caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis) is highly contagious, and can be spread through the air from an infected person to others.
Kamoona Firas Mohammad Hussein   +1 more
doaj   +1 more source

Prognostic value of complex assessment of Ki-67, tumor necrosis factor α, CD20 and CD31 expression in non-small cell lung cancer

open access: yesУспехи молекулярной онкологии, 2021
Introduction. Non-small cell lung cancer is a common cancer with a poor prognosis. Modern researchers conduct many studies devoted to understanding the molecular mechanisms of its pathogenesis. Modern advances in immunotherapy have significantly improved
O. V. Kovaleva   +5 more
doaj   +1 more source

On the markers for schizophrenia

open access: yesОбозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2021
Summary. The study of various markers indicating an imbalance in both the neurotransmitter and immune systems observed in patients with schizophrenia is currently of great scientific and practical interest.
A. N. Erichev   +4 more
doaj   +1 more source

Non-Hodgkin lymphoma of cauda equina: A diagnostic conundrum: Case report

open access: yesAdvanced Biomedical Research, 2023
Primary central nervous system lymphoma (PCNSL) is uncommon with scarce cases having involvement of the spinal cord. Cauda equina is unique in its location and shows very rare involvement by diseases pathologies.
Pranati Misra   +5 more
doaj   +1 more source

Important Diagnostic Clues for Diagnosing Splenic Marginal Zone Lymphoma in Absence of Splenic Histology [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Splenic Marginal Zone Lymphoma (SMZL) is a rare B-cell neoplasm comprising less than 2% of non-Hodgkin lymphomas. We hereby report a case of SMZL in a 66-year-old female who presented with fever and massive splenomegaly.
Anisha Mohanpuria   +4 more
doaj   +1 more source

Diagnostic Performance of PD-L1 versus PD-1 Expression in Circulating CD20 Cells in Diffuse Large B-Cell Lymphoma

open access: yesAntibodies, 2022
This study aimed to investigate PD-L1 and PD-1 expression in circulating CD20+ cells in diffuse larger B-cell lymphoma (DLBCL) and to evaluate the predictive and diagnostic performance of PD-L1 versus PD-1 expression in circulating CD20+ cells in DLBCL ...
Manal Mohamed Saber
doaj   +1 more source

Neolymphogenesis and Immunogistogochemical Study of Lymph Nodes in Breast Cancer

open access: yesКреативная хирургия и онкология, 2020
Background. Our previous studies have shown that postnatally formed lymph nodes (PNFLN) can serve as a source of biological signals activating antitumour immune reactions and suppressing the spread of metastatic malignant cells.Aim.
Sh. Kh. Gantsev   +3 more
doaj   +1 more source

CD20-targeting in B-cell malignancies: novel prospects for antibodies and combination therapies [PDF]

open access: yes, 2016
Expression of CD20 antigen by the most of transformed B cells is believed to be the driving force for targeting this molecule by using anti-CD20 monoclonal antibodies. While it is true that most lymphoma/leukemia patients can be cured, these regimens are
Ahmadzadeh, V.   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy